Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLegal & General Regulatory News (LGEN)

Share Price Information for Legal & General (LGEN)

Share Price is delayed by 15 minutes
Get Live Data
291.00    0.90 (0.31%)
Bid:
291.20
Ask:
291.40
Spread: 0.20 (0.069%)
Market Cap: £15.91b
LGEN Live PriceLast checked at - London Stock Exchange

Intraday Legal & General Share Chart

Directorate Change

17 Jun 2022 07:00

RNS Number : 2184P
Legal & General Group Plc
17 June 2022
 

 

Legal & General Group Plc Board announces the appointment of Carolyn Johnson as a non-executive director of Legal & General Group Plc

 

 

17 June 2022

 

The Board of Legal & General Group Plc (the "Company") is pleased to announce the appointment of Carolyn Johnson as an independent non-executive director of the Company with immediate effect. Carolyn will join the Group Audit, Group Risk and Group Nominations and Corporate Governance Committees upon appointment.

 

Carolyn has extensive knowledge of the insurance and financial services industries following a 30-year executive career in the United States. In particular, she has deep experience in the life insurance market, having held senior roles at AIG, Voya Financial and Protective Life Corporation.

 

Carolyn Johnson was a director of Majesco, Inc until 2020. There is no other additional information required to be disclosed in relation to Carolyn Johnson pursuant to LR 9.6.13R of the Listing Rules of the Financial Conduct Authority.

 

Sir John Kingman, Group Chairman, said:

 

"I am delighted to welcome Carolyn to the Group Board. Carolyn brings with her a wealth of experience in insurance and in financial services more generally. Her appointment will strengthen the Board's engagement with our successful and growing US businesses in life insurance, asset management and pension risk transfer. I very much look forward to working with her."

 

In addition, the Board of the Company is pleased to annouce that Laura Wade-Gery will become chair of the Group Technology Committee with effect from 1 September 2022.

 

Laura Wade-Gery joined the Board on 3 January 2022 as a non-executive director and is a member of the Group Technology Committee and Group Nominations and Corporate Governance Committee.

 

Notes to Editors

Legal & General Group Plc

 

Established in 1836, Legal & General is one of the UK's leading financial services groups and a major global investor, with over £1.4 trillion in total assets under management of which a third is international. L&G also provides powerful asset origination capabilities. Together, these underpin our leading retirement and protection solutions: we are a leading international player in pension risk transfer, in UK and US life insurance, and in UK workplace pensions and retirement income. As at 16 June 2022, Legal & General has a market capitalisation of £14.6 billion.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAMZGMVGVDGZZZ
Date   Source Headline
1st Oct 20195:00 pmRNSDirector/PDMR Shareholding
1st Oct 20195:00 pmRNSDirector/PDMR Shareholding
1st Oct 20195:00 pmRNSTotal Voting Rights
30th Sep 20195:00 pmRNSDirector/PDMR Shareholding
30th Sep 20195:00 pmRNSDirector/PDMR Shareholding
30th Sep 20197:00 amRNSHolding(s) in Company
27th Sep 20195:00 pmRNSDirector/PDMR Shareholding
26th Sep 20199:45 amRNSHolding(s) in Company
23rd Sep 20197:00 amRNSHolding(s) in Company
19th Sep 20195:08 pmRNSHolding(s) in Company
3rd Sep 20195:00 pmRNSDirector/PDMR Shareholding
3rd Sep 20191:00 pmRNSHoldings in Company
2nd Sep 20195:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20195:00 pmRNSTotal Voting Rights
2nd Sep 20195:00 pmRNSDirector/PDMR Shareholding
2nd Sep 20194:07 pmRNSDirectorate Change
23rd Aug 20198:28 amRNSHolding(s) in Company
9th Aug 20199:01 amRNSHolding(s) in Company
7th Aug 20197:00 amRNSL&G Half Year Results 2019 Part 3
7th Aug 20197:00 amRNSL&G Half Year Results 2019 Part 2
7th Aug 20197:00 amRNSL&G Half Year Results 2019 Part 1
5th Aug 20196:23 pmRNSHolding(s) in Company
2nd Aug 20195:00 pmRNSDirector/PDMR Shareholding
1st Aug 20195:00 pmRNSDirector/PDMR Shareholding
1st Aug 20195:00 pmRNSDirector/PDMR Shareholding
1st Aug 20195:00 pmRNSTotal Voting Rights
26th Jul 20194:53 pmRNSTR-1: Notification of Major Holdings
25th Jul 20194:27 pmRNSDirector Declaration
24th Jul 20193:26 pmRNSHolding(s) in Company
23rd Jul 20199:28 amRNSHolding(s) in Company
19th Jul 20195:00 pmRNSDirector/PDMR Shareholding
19th Jul 201910:03 amRNSHolding(s) in Company
18th Jul 20193:26 pmRNSHolding(s) in Company
5th Jul 20194:01 pmRNSHolding(s) in Company
2nd Jul 20195:00 pmRNSDirector/PDMR Shareholding
2nd Jul 201910:03 amRNSDirector Declaration
1st Jul 20195:00 pmRNSDirector/PDMR Shareholding
1st Jul 20195:00 pmRNSBlock listing Interim Review
1st Jul 20195:00 pmRNSDirector/PDMR Shareholding
1st Jul 20195:00 pmRNSTotal Voting Rights
18th Jun 20195:00 pmRNSHolding(s) in Company
14th Jun 20193:03 pmRNSHolding(s) in Company
11th Jun 20195:00 pmRNSDirector/PDMR Shareholding
11th Jun 20195:00 pmRNSDirector/PDMR Shareholding
10th Jun 20195:00 pmRNSDirector/PDMR Shareholding
7th Jun 20191:32 pmRNSHolding(s) in Company
6th Jun 20197:00 amRNSPension Risk Transfer Transaction
5th Jun 20195:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20195:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20195:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.